Posted in | News | Display

Smallest DCM Extends Compensation up to 200 km

TeraXion Inc ., a technology leader in the development and manufacturing of optical components for high-speed communication networks, announced it will launch the next generation of its popular ClearSpectrum™ chromatic dispersion compensation module at ECOC 2006.

The new ClearSpectrum™-DCMX boasts the industry's smallest package and offers enhanced performance for high speed metro and long-haul DWDM networks. It is designed to compensate links from 20 to 200 km in a single, low-loss module. The ClearSpectrum™-DCMX is an attractive alternative to dispersion compensating fibre (DCF) in cost-sensitive networks since its small footprint minimizes space and its low insertion loss (<3 dB) reduces amplification requirements. Based on TeraXion's advanced multi-channel fibre Bragg grating technology, the compensators can be cascaded in networks up to and beyond 2000 km.

“The combined low-loss and extended-reach features of this new platform deliver system manufacturers the design flexibility they require for future network architectures—an important consideration that is not adequately addressed by incumbent DCF-based modules,” said Dr. Martin Guy, Vice President of Product Management and Technology at TeraXion. “The market is embracing our DCMs and we have already received volume order commitments from tier-one system manufacturers,” added Dr. Guy.

The ClearSpectrum™-DCMX will be on display for the first time during the 2006 ECOC exhibition, September 25-27th in Cannes, France. A number of technical papers demonstrating the system performance of the DCMX will also be presented during the conference.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.